The importance of involving the patient at all stages of trials post-pandemic has never been clearer
There’s opportunity as well as danger in the billion healthcare searches made every day. Why isn’t pharma tuning in?
Pharma can improve outcomes, products and HCP relationships using technology to capture patients’ day-to-day experience of their disease
Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can le...